Does MS Get Worse at Night? Reasons Why & What to Do

Understand why multiple sclerosis symptoms may intensify at night and learn effective strategies for nocturnal relief.

Many people with multiple sclerosis notice that their symptoms feel worse as the day wears on and into the night. This is not imagined. Research using real-time symptom tracking confirms that pain, fatigue, and cognitive difficulties all tend to climb from morning to bedtime, and a cluster of nighttime-specific problems can pile on after dark. The reasons range from how the body’s internal clock interacts with the immune system to mechanical issues like bladder dysfunction and involuntary leg movements that specifically disrupt sleep.

Symptoms Really Do Build Across the Day

Clinicians have long recognized that MS symptoms fluctuate on an hour-to-hour basis throughout a 24-hour cycle. But only fairly recently has anyone tracked those swings in real time using smartphones. A study that had people with MS report their symptoms multiple times a day found that pain, fatigue, depressive symptoms, and cognitive symptoms all increased in intensity from waking to bedtime. Fatigue showed the steepest climb. The pattern also differed by sex: women experienced a continuous increase from morning to bedtime, whereas fatigue in men tended to level off after about 7 p.m.

This matters because by the time you reach evening, you may already be experiencing your worst symptom levels of the day. Anything that then interferes with sleep turns a bad evening into a miserable night, and the two problems feed each other.

Leg Spasms and Pain That Wake You Up

Spasticity is one of the most common culprits behind disrupted sleep in MS. Involuntary muscle tightening and spasms in the legs can jerk you awake repeatedly, and the discomfort from sustained stiffness can make it hard to fall back asleep. A study that systematically surveyed sleep problems in MS found that difficulties falling asleep and frequent awakenings due to leg spasms or discomfort were among the leading complaints. The authors concluded that sleep disturbance in MS is common but poorly recognized, and is often driven by leg spasms, pain, immobility, nocturia, or medication side effects.

Neuropathic pain, the burning, shooting, or tingling sensations caused by nerve damage itself, adds another layer. Pain from MS tends to develop once the disease is well established and often persists indefinitely. It can result from the direct effects of nerve injury or from problems tied to immobility, and it does not simply switch off when you lie down. In fact, the absence of daytime distractions can make nerve pain feel more prominent at night. Lying still in one position for hours can also worsen discomfort in limbs already affected by spasticity or weakness.

Bladder Problems and the Nocturia Cycle

Getting up to urinate multiple times per night is strikingly common in MS. A study of 309 patients found that isolated nocturia or nighttime urinary incontinence is a frequent problem, with an overactive bladder muscle being the main mechanism. But the story is more complex than just an irritable bladder. MS can cause neurogenic bladder dysfunction through several routes: the bladder muscle may contract when it should not, the sphincter may not coordinate properly with the bladder, or the bladder may not empty fully, leaving less room for urine produced overnight. On top of that, some people with MS produce abnormally large volumes of urine at night, a condition called nocturnal polyuria. This can stem from autonomic dysfunction affecting blood pressure regulation at night, or from demyelinating lesions in the spinal cord disrupting the normal nighttime rise in antidiuretic hormone, which ordinarily tells the kidneys to concentrate urine while you sleep.

The downstream consequences extend beyond lost sleep. Repeatedly getting out of bed in the dark, often with legs weakened by spasticity or poor balance from MS, creates a real fall risk. Something as simple as a motion-sensing nightlight in the bedroom and along the path to the bathroom can reduce the chance of tripping over furniture or clutter at night.

Restless Legs Syndrome

People with MS develop restless legs syndrome at considerably higher rates than the general population. One study of relapsing-remitting MS found restless legs in about 22% of patients, compared to roughly 12% of healthy volunteers. Those who had restless legs also scored significantly worse on measures of anxiety, depression, sleep quality, fatigue, and overall quality of life. A separate pilot study in Saudi Arabia placed the figure even higher, at about 30%, and found a strong link between restless legs, greater disability, worse sleep, and higher fatigue.

Restless legs syndrome produces an irresistible urge to move the legs, usually accompanied by uncomfortable crawling or aching sensations. The hallmark of the condition is that symptoms emerge at rest and worsen in the evening and at night, which makes falling asleep genuinely difficult. For someone with MS who is already dealing with spasticity and fatigue, restless legs can tip a mediocre night into an awful one. The overlap between the two conditions is thought to involve disrupted dopamine signaling and possibly spinal cord lesions, though the exact mechanism is still debated.

Sleep Apnea Linked to Brainstem Damage

Sleep apnea is another nighttime problem that shows up in MS at higher-than-expected rates, and the connection appears to go beyond the usual risk factors of weight and age. Research has found that MS patients with brainstem involvement show significantly more severe sleep-disordered breathing compared to those without brainstem lesions. Specifically, people with MS and brainstem damage had higher scores on the apnea-hypopnea index, which measures how often breathing stops or becomes dangerously shallow during sleep. Patients without brainstem involvement did not show the same degree of difference from control groups.

A more recent study drilled down further and found that after controlling for age, sex, body mass index, disease duration, and other known risk factors, the number of lesions in the midbrain and pons (areas of the brainstem involved in breathing regulation) was significantly associated with how severe the apnea was. This is important because sleep apnea in people with MS can fly under the radar. A clinician might assume that daytime fatigue is entirely from MS itself, when in reality, undiagnosed apnea is robbing the person of restorative sleep every night. If you have MS and snore loudly, wake up gasping, or feel unrested despite what seemed like enough sleep, it is worth asking about a sleep study.

How Body Temperature Plays a Role

Heat sensitivity is a well-known feature of MS. An estimated 60 to 80% of people with the condition experience temporary worsening of symptoms when their body temperature rises, because even a small increase in temperature can slow or block nerve signals in demyelinated axons. This might seem like it would make nighttime better, since body temperature naturally drops during sleep. And for some people, cool nighttime temperatures do bring relief. But the picture is not that tidy.

The body’s core temperature typically peaks in the late afternoon and early evening before beginning its nighttime descent. If you are already accumulating fatigue and symptom intensity across the day, that late-day temperature peak can add another push in the wrong direction right around the time you are trying to wind down. Overheated bedrooms, heavy bedding, or even a warm bath before bed can keep body temperature elevated long enough to interfere with sleep onset. On the flip side, some people with MS have impaired thermoregulation and may not cool down as efficiently as expected, which means the natural nighttime temperature drop comes later or is less pronounced. Keeping the bedroom cool and using breathable bedding are small adjustments that can make a measurable difference.

Melatonin and Circadian Disruption

Melatonin, the hormone that signals the brain it is time to sleep, appears to be affected by MS in ways researchers are still working out. One study found that untreated MS patients had significantly lower levels of a melatonin metabolite and disrupted circadian regulation of its secretion compared to healthy controls. Treatment with interferon-beta increased melatonin output and was associated with improved fatigue. However, a later study looking specifically at relapsing-remitting MS found no evidence of a generally disturbed melatonin rhythm, though longer disease duration was linked to significantly lower melatonin levels.

What this probably means in practice is that melatonin disruption is not universal in MS but becomes more likely the longer someone has had the disease, and it may depend on whether and how MS is being treated. Melatonin also has immune-modulating properties beyond its role in sleep, so the relationship with MS is not a simple matter of “take a supplement and sleep better.” The neuroendocrine and immune systems communicate back and forth through shared chemical messengers, and disruptions at any level can influence both susceptibility to flares and symptom severity. This is an area where the evidence is still evolving, and blanket advice about melatonin supplements does not capture the complexity.

Why Poor Sleep Makes Daytime MS Worse

The nighttime problems described above do not stay contained to nighttime. Disrupted sleep feeds back into daytime functioning in ways that can feel like the disease itself is progressing, even when it is not. A study examining the link between sleep quality and fatigability in MS found that multiple measures of poor sleep were significantly associated with both physical and cognitive fatigability. However, when the researchers controlled for depression, the connection to cognitive fatigability disappeared, and the link to physical fatigability weakened.

That finding is revealing. It suggests that poor sleep, depression, and fatigue form a tightly woven cluster in MS, and untangling which is driving which requires careful attention. A person who assumes their crushing daytime fatigue is simply “the MS” may actually be dealing with treatable sleep disruption, undertreated depression, or both. This is one of the most actionable takeaways: if your MS seems to be getting worse, a detailed look at sleep quality and mood should be part of the conversation with your neurologist, not an afterthought.

The Brain’s Overnight Cleaning System

There is growing interest in how sleep disruption in MS may affect the brain’s waste clearance, known as the glymphatic system. This system works primarily during sleep, especially during deep slow-wave sleep, by flushing cerebrospinal fluid through brain tissue to remove harmful proteins and metabolic waste. During wakefulness, the process is largely suppressed because higher levels of noradrenaline reduce the space between brain cells, leaving less room for fluid to flow. Animal research has shown that waste clearance drops by roughly half during wakefulness compared to sleep.

For people with MS, the implications are concerning. If spasticity, nocturia, restless legs, or apnea repeatedly fragment sleep, you are not just losing hours of rest. You may also be losing the deep sleep phases when the brain most effectively clears inflammatory byproducts. Researchers have begun exploring whether impaired glymphatic function contributes to neurodegeneration in MS, though this line of investigation is still early. It does add another reason to take sleep disruption seriously rather than treating it as an inconvenient side effect of having MS.

What You Can Do About Nighttime Symptoms

There is no single fix for nighttime worsening in MS, because the problem is not a single thing. The most effective approach starts with identifying which specific nighttime issues are at play and addressing each one. Here are the most evidence-informed strategies:

  • Talk to your neurologist about a sleep study. If you snore, wake up gasping, or feel unrefreshed despite adequate hours in bed, screening for sleep apnea is worthwhile given its elevated prevalence in MS and its connection to brainstem lesions.
  • Address nocturia directly. Limiting fluids in the two hours before bed helps, but the underlying cause matters. If the problem is an overactive bladder, medications that calm the bladder muscle can reduce nighttime awakenings. If the problem is excessive nighttime urine production, a different approach targeting fluid balance may be needed. Your care team can distinguish between these with straightforward testing.
  • Manage spasticity before bed. Gentle stretching of the legs before sleep can reduce the severity and frequency of overnight spasms. Medications for spasticity (like baclofen or tizanidine) are sometimes dosed specifically at bedtime to cover the overnight hours. Adjusting the timing of an existing spasticity medication can sometimes help without increasing the total dose.
  • Screen for restless legs. If you feel an overwhelming urge to move your legs in the evening, this is a distinct condition from spasticity and may respond to different treatments. Iron deficiency is a common and easily correctable contributor to restless legs, so checking ferritin levels is a reasonable first step.
  • Keep the bedroom cool. Given how many people with MS are sensitive to heat, a cool sleeping environment is not a luxury but a targeted intervention. Lightweight, breathable bedding and a room temperature on the cooler side of comfortable can help both with falling asleep and with reducing temperature-related symptom flares overnight.
  • Reduce fall risk. Motion-sensing nightlights along the path from bed to bathroom, removing loose rugs, and keeping the floor clear of clutter are simple measures that matter disproportionately when you are getting up with impaired balance in the dark.

One experimental intervention that has shown some promise is bright-light therapy in the morning. A small trial had people with MS use a bright white light device for 30 minutes each morning for two weeks. While the primary fatigue measure did not reach a statistically significant difference between the bright-light group and the control group, a secondary fatigue measure did show improvement in the bright-light group, including both the physical and cognitive domains. The idea is that strengthening the circadian signal in the morning may help regulate the sleep-wake cycle and improve overall energy. This is not a proven treatment yet, but morning light exposure is low-risk and fits easily into a daily routine.

The Toll on Caregivers

Nighttime MS symptoms do not affect only the person who has MS. A scoping review of sleep in caregivers of people with MS found that the prevalence of self-reported poor sleep ranged from roughly 39% to 72%, and caregivers consistently reported more sleep difficulties than non-caregivers. Sleep disruption ranked among the top four most commonly reported sources of caregiver strain, with over half of caregivers in one study indicating that their sleep was disturbed. Poor sleep quality in caregivers was also correlated with higher levels of anxiety and depression.

This creates a cycle that can destabilize both people in the household. A caregiver who is sleep-deprived provides less effective support, which increases the risk of falls and missed medications for the person with MS, which in turn worsens nighttime symptoms and further fragments the caregiver’s sleep. Addressing the MS-related nighttime symptoms often improves the caregiver’s sleep as well, making it a shared investment. Practical solutions like scheduled nighttime assistance, bedroom modifications, or even separate sleeping arrangements on particularly bad nights are not signs of failure. They are strategies that protect both people.